•  : 



Brand name – Palbocent

Generic name – Palbociclib

Manufacturer – Incepta

Strength – 125mg

Dosage Form – Capsules

Composition – Palbociclib

Indication – Breast Cancer

Storage – at 20° – 25° C


Palbocent 125 mg capsules is a target therapy medication that is used to treat breast cancer. Palbociclib is the generic name of this medication and it is a cyclin-dependent kinase inhibitor that showcases antineoplastic properties. Palbocent is based on a prescription and should be taken with food.


Palboxen 125mg is a piperazine pyridopyrimidine that is a cyclin-dependent kinase (CDK4/6) inhibitor. It works by binding to the ATP pocket and blocking the cell division process. Thus, it exhibits anti-tumour activity by inhibiting the cell division of the cancerous cells. Additionally, it stops the spreading of the tumors throughout the body.


Side Effects

  • Rashes
  • Irregular heartbeat
  • Nosebleeds
  • Increased bruises
  • Hair loss
  • Tingling of arms and feet
  • Shortness of breath
  • Diarrhea
  • Vomiting
  • Loss of appetite
  • Extreme fatigue
  • Dizziness
  • Dry skin



Palbocent 125 mg capsules is a prescription-based medication and it should be taken one time every day with food.

Missed dose

It is advisable to avoid missing any doses of Palbocent in case you miss a dose consult your doctor immediately.


In case of an overdose of Palbocent 125mg, contact your doctor or any healthcare provider and seek medical attention immediately.



  • Palbocent can cause an allergic reaction in some patients thus it is important to gather complete information about the tablets before starting the treatment.
  • Inform the doctor about all the prescription, and non-prescription medicines and vitamins that you take since Palbocent can interact with them.
  • It is advisable to avoid pregnancy and breastfeeding during and 3 weeks after the last dose since Palbocent can cause harm to the fetus.
  • Palbocent 125 mg capsules is a prescription-based medication that decreases fertility in male patients. Also, patients with female partners should avoid pregnancy till three months after the last dose.
  • It is advisable to avoid alcohol and driving the treatment with Palbocent.
  • Palbocent can often interact with some diseases like – liver and kidney impairments.